METHOD FOR TREATING DYSFUNCTIONAL UTERINE HEMORRHAGES AT GLANDULAR-CYSTIC HYPERPLASIA AND ENDOMETRIAL POLYPS Russian patent published in 2007 - IPC A61K33/18 A61P15/00 

FIELD: medicine, gynecology, endocrinology.

SUBSTANCE: it is necessary to detect the level of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) during the period of preovulatory peak, the FSH/LH ratio, the quantity of dominant follicles. During the next menstrual cycle on the day of the onset of LH level growth one should perorally introduce 2000 mcg potassium iodide (PI) in case of one follicle under maturation and 3000 mcg PI at two and more follicles under maturation. During the period of preovulatory FSH and LH peak one should detect their level and ratio, and on the day of maximal secretory activity of endometrial glands it is important to estimated the thickness of endometrium. At decreased FSH/LH ratio and decreased endometrial thickness up to the norm it is necessary to prescribe the repeated intake of the above-mentioned dosage of the preparation but in 3 mo, not earlier and in 6 mo, not later. In case of normal FSH/LH and endometrial thickness the maintenance dosage (MD) corresponds to 1000 mcg PI on the day of the onset of LH level growth at frequency being once/3 mo. In case of increased FSH/LH MD corresponds to 1000 mcg PI at frequency of once/2 mo. In case of amenorrhea without climacteric FSH and LH values MD corresponds to 1000 PI on the day that correspond to previously detected onset of LH level growth, at frequency being once/3 mo till achieving climacteric FSH and LH values. The innovation provides efficient therapy and prophylaxis of dysfunctional uterine hemorrhages at no side effects and no usage of hormonal preparations.

EFFECT: higher efficiency of therapy.

3 cl, 3 ex